Tarceva
Term · Oncology and biomedicine · MLC-T-ONC-008523
A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. Tarceva blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called CP-358,774, erlotinib hydrochloride, and OSI-774.
| Identifier | MLC-T-ONC-008523 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CP-358,774; erlotinib hydrochloride; OSI-774 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008523",
"term": "Tarceva",
"field": "Oncology and biomedicine",
"definition": "A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. Tarceva blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called CP-358,774, erlotinib hydrochloride, and OSI-774.",
"synonyms": [
"CP-358,774",
"erlotinib hydrochloride",
"OSI-774"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/tarceva/"
}
Record 15,997 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.